Number of participants with diabetes by trial Cholesterol Treatment Trialists' (CTT) Collaborators...

8
Number of participants with diabetes by trial Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25

description

Proportional effects on cause-specific mortality per mmol/L reduction in LDL cholesterol in participants presenting with or without diabetes Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25

Transcript of Number of participants with diabetes by trial Cholesterol Treatment Trialists' (CTT) Collaborators...

Page 1: Number of participants with diabetes by trial Cholesterol Treatment Trialists' (CTT) Collaborators Lancet…

Number of participants with diabetes by trial

Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25

Page 2: Number of participants with diabetes by trial Cholesterol Treatment Trialists' (CTT) Collaborators Lancet…

Baseline characteristics of participants presenting with or without diabetes

Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25

Page 3: Number of participants with diabetes by trial Cholesterol Treatment Trialists' (CTT) Collaborators Lancet…

Proportional effects on cause-specific mortality per mmol/L reduction in LDL cholesterol in participants presenting with or without diabetes

Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25

Page 4: Number of participants with diabetes by trial Cholesterol Treatment Trialists' (CTT) Collaborators Lancet…

Proportional effects on major vascular events per mmol/L reduction in LDL cholesterol in participants presenting with or without diabetes

Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25

Page 5: Number of participants with diabetes by trial Cholesterol Treatment Trialists' (CTT) Collaborators Lancet…

Proportional effects on major vascular events per mmol/L reduction in LDL cholesterol in participants

with and without diabetes by history of vascular disease

Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25

Page 6: Number of participants with diabetes by trial Cholesterol Treatment Trialists' (CTT) Collaborators Lancet…

Proportional effects on major vascular events per mmol/L reduction in LDL cholesterol by baseline prognostic factors in participants with diabetes

Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25

Page 7: Number of participants with diabetes by trial Cholesterol Treatment Trialists' (CTT) Collaborators Lancet…

Proportional effects on major vascular events per mmol/L reduction in LDL cholesterol by baseline lipid profi le in participants with diabetes

Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25

Page 8: Number of participants with diabetes by trial Cholesterol Treatment Trialists' (CTT) Collaborators Lancet…

Proportional effects on major vascular events per mmol/L reduction in LDL cholesterol, by year, in participants with and without diabetes

Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:117-25